Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ...
Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...
The Sing IMT improved distance and near vision at 6 months in patients with late-stage age-related macular degeneration, with ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
An implantable miniature telescope can improve distance and near vision in AMD with little impact on the corneal endothelium.
The objective of this trial was to evaluate safety and tolerability and identify dose level for further evaluation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback